Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: A meta-analysis

National Medical Journal of China

Volumn 86, Issue 31, 2006, Pages 2182-2187

  Huang, Qing Shui ^a   Wan, La Gen ^a   Luo, Zhong Qin ^a   Le, Ai Ping ^a   Wang, Wen Qiang ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Antibodies; Arthritis; Meta analysis; Rheumatoid

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ARTICLE; BIBLIOGRAPHIC DATABASE; CALCULATION; CLINICAL TRIAL; COCHRANE LIBRARY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; DISEASE DURATION; EMBASE; HUMAN; IMMUNOASSAY; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; HUMANS; PEPTIDES, CYCLIC;

EID: 33749359400     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bukhari M, Harrison B, Lunt M, et al. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum, 2001, 44:1248-1253.
2. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31:315-324.
3. Chinese source. 2005, 85:1261-1265.
4. Schellekens GA, Visser H, de Jong BA. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43:155-163.
5. Chinese source. 2001, 80:20-24.
6. Chinese source. 2003, 83:360-361.
7. Chinese source. 2005,85:276-278.
8. Moses LE, Shapiro D, Littenberg B. Combibing independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional consideration. Statistics in Medicine, 1993, 12:1293-1316.
9. Fusconi M, Vannini A, Dallaglio AC, et al. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis. Aliment Pharmacol Ther, 2005, 22:951-955.
10. Bas S, Genevay S, Meyer O, et al. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford), 2003, 42:677-680.
11. Alexander G, Herbert P, Hwerbert K. Peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann NY Acad Sci, 2005, 1050:295-303.
12. Vittecoq O, Incaurgarat B, Jouen-Beades F, et al. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol, 2004, 135: 173-180.
13. Nell VP, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis, 2005, 64:1731-1736.
14. Sauerland U, Becker H, Seidel M, et al. Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci, 2005, 1050:314-318.
15. Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis, 2003, 62:870-874.
16. Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem, 2001, 47:1089-1093.
17. Vallbracht I, Rieber J, Oppermann M, et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis, 2004, 63:1079-1084.
18. Choi SW, Lim MK, Shin DH, et al. Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci, 2005, 20:473-478.
19. Samanci N, Ozdem S, Mutlu D, et al. Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis. J Natl Med Assoc, 2005, 9:1120-1126.
20. De Seny D, Fillet M, Meuwis MA, et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum, 2005, 52:3801-3812.
21. Dubucquoi S, Solau-Gervais E, Lefranc D, et al. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis, 2004, 63:415-419.
22. Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res, 2000, 2:236-243.
23. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis, 2004, 63:1587-1593.
24. Chinese source. 2005, 9:700-701.
25. Chinese source. 2004, 8:513-516.
26. Chinese source. 2003, 26:484-487.
27. Chinese source. 2001, 5:281-284.
28. Chinese source. 2004, 8:360-362.
29. Chinese source. 2003, 7:635-637.
30. Chinese source. 2004, 20:52-54.
31. Saraux A, Berthwlot JM, Chales G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum, 2001, 44:2485-2491.
32. Visser H. Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol, 2005, 19:55-72.
33. Forslind K, Ahlme' n M, Eberhardt K, et al. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis, 2004, 63:1090-1095.
34. Kastbom A, Strandberg G, Lindroos A, et al. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis, 2004, 63: 1085-1089.
35. Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis, 2003, 62:427-430.
36. Van Gaalen FA, Visser H, Huizinga TW. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis, 2005, 64:1510-1512.
37. Gottenberg JE, Mignot S, Nicaise-Rolland P. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis, 2005, 64:114-117.
38. Rennie D. Improving reports of studies of diagnostic tests: the STARD Initiative. JAMA, 2003, 289:89-90.